APPIA News Release — November 2, 2021
APPIA and NSH Partner to Offer CEU Around TOPS Program
The Anatomical Pathology Patient Interest Association (APPIA) and the National Society for Histotechnology (NSH) are pleased to announce an educational partnership for APPIA’s Tissue Optimization and Pre-analytic Standardization (TOPS) Program.
Under the terms of the partnership, NSH will utilize their e-learning Management System to issue continuing education credits (CEUs) for the TOPS Program, allowing histology and medical laboratory professionals to maintain their certification and licensure requirements. NSH will provide 1 continuing education credit to registrants that complete the online course.
September 15, 2021 2:30pm – 2:45pm (EST)
Robert Lott, HTL(ASCP) will be hosting an APPIA-sponsored Express Talk about TOPS.
Mr. Lott is a frequent speaker and educator at both national and regional National Society for Histotechnology meetings and one of the collaborative authors of the complete APPIA TOPS Program. He has narrated the TOPS Program for Laboratory Personnel (Histotechnologists and Medical Technologists) – Available Here.
APPIA News Release — July 12, 2021
APPIA Announces 2021-2023 Officers and Directors
The Anatomical Pathology Patient Association is pleased to announce the election of a slate of officers and directors for 2021-2023.
Erico von Bueren was elected to a two-year term as President, stepping into the seat previously held by Beth Sheppard, who continues to serve on the APPIA Board of Directors as Immediate Past President.
Mr. von Bueren is Director of Marketing for Sakura Finetek USA, Inc…. Read More
APPIA News Release — June 23, 2021
APPIA Article in AIMM Journal Recommends Solutions for Low-Incidence Validation of Rare Tissues and Antigens
A new article published in the Applied Immunohistochemistry & Molecular Morphology Journal outlines recommendations from the Anatomical Pathology Patient Interest Association (APPIA) for practical solutions available to anatomic pathology laboratories for validation of immunohistochemistry (IHC) staining for low-incidence, rare tissues and antigens with low frequency of occurrence.
These recommendations are in response to the comprehensive guidelines… Read More